Immediate Impact
1 by Nobel laureates 2 from Science/Nature 50 standout
Citing Papers
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Multifunctional nanoparticle-mediated combining therapy for human diseases
2024 Standout
Works of Surai Jones being referenced
Phase I Study of the Anti-CD22 Antibody–Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Surai Jones | 87 | 125 | 33 | 49 | 12 | 276 | |
| Giacomo Loseto | 85 | 151 | 26 | 52 | 24 | 330 | |
| Seri Anderson | 107 | 56 | 31 | 28 | 12 | 314 | |
| Thomas Georgi | 109 | 63 | 42 | 8 | 10 | 263 | |
| Helen Curley | 86 | 180 | 5 | 8 | 6 | 282 | |
| Evan D. Slater | 19 | 76 | 21 | 55 | 7 | 305 | |
| Justin Smith | 179 | 91 | 116 | 36 | 23 | 329 | |
| Emily Peterson | 13 | 143 | 13 | 8 | 9 | 280 | |
| Abdullah A. Alsharm | 16 | 195 | 22 | 23 | 17 | 287 | |
| Elizabeth C. Chase | 141 | 148 | 13 | 17 | 14 | 283 | |
| Moawia Mohammed Ali Elhassan | 18 | 80 | 24 | 30 | 28 | 231 |
All Works
Loading papers...